The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGEX THEREPEUTICS INC | COM | 00848H108 | 107 | 185,185 | SH | SOLE | 185,185 | 0 | 0 | ||
| ALTIMMUNE INC | COM NEW | 02155H200 | 585 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CIMPRESS PLC | SHS EURO | G2143T103 | 151,963 | 3,906,492 | SH | SOLE | 3,906,492 | 0 | 0 | ||
| CREDIT ACCEP CORP MICH | COM | 225310101 | 772,779 | 1,632,368 | SH | SOLE | 1,632,368 | 0 | 0 | ||
| GLOBAL INDUSTRIAL COMPANY | COM | 37892E102 | 43,215 | 1,279,677 | SH | SOLE | 1,279,677 | 0 | 0 | ||
| HUMACYTE INC | COM | 44486Q103 | 1,824 | 568,246 | SH | SOLE | 568,246 | 0 | 0 | ||
| LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 2,926 | 1,851,851 | SH | SOLE | 1,851,851 | 0 | 0 | ||
| SANA BIOTECHNOLOGY INC | COM | 799566104 | 785 | 122,097 | SH | SOLE | 122,097 | 0 | 0 | ||
| VAPOTHERM INC | COM | 922107107 | 6,470 | 2,557,243 | SH | SOLE | 2,557,243 | 0 | 0 | ||
| WAYFAIR INC | CL A | 94419L101 | 166,540 | 3,823,239 | SH | SOLE | 3,823,239 | 0 | 0 | ||
| WORLD ACCEP CORP DEL | COM | 981419104 | 228,688 | 2,037,495 | SH | SOLE | 2,037,495 | 0 | 0 | ||
| YELP INC | CL A | 985817105 | 80,804 | 2,909,751 | SH | SOLE | 2,909,751 | 0 | 0 | ||